POLYMED

Poly Medicure Share PricePoly Medicure

₹1,592.8
67.15 (4.4%)
  • Advice
  • Hold
As on 03 December, 2023 | 23:22 BSE: 531768 NSE: POLYMEDISIN: INE205C01021

Poly Medicure Performance

Day Range

  • Low 1,530.00
  • High 1,608.00
₹ 1,592.8

52 Week Range

  • Low 820.30
  • High 1,608.00
₹ 1,592.8
  • Open Price1,538.60
  • Previous Close1,525.65
  • Volume159007

Start SIP in Poly Medicure

Start SIP

Poly Medicure Share Price

  • Over 1 Month 13.66%
  • Over 3 Month 14.23%
  • Over 6 Month 63.67%
  • Over 1 Year 65.1%

Poly Medicure Key Statistics

P/E Ratio 65.4
PEG Ratio 1
Market Cap Cr 15,286
Price to Book Ratio 12.3
EPS 18.2
Dividend 0.2
Relative Strength Index 66.3
Money Flow Index 71.24
MACD Signal 32.09
Average True Range 55.03

Poly Medicure Investment Rating

  • Master Rating:
  • Poly Medicure has an operating revenue of Rs. 1,249.81 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 21% is great, ROE of 14% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 34% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 95 which is a GREAT score indicating consistency in earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 31 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Poly Medicure Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 320306293272264239244
Operating Expenses Qtr Cr 237220212203198191188
Operating Profit Qtr Cr 83858268664857
Depreciation Qtr Cr 15151514141414
Interest Qtr Cr 2225011
Tax Qtr Cr 1920161716913
Net Profit Qtr Cr 59615748452938
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,104918
Operating Expenses Annual Cr 804667
Operating Profit Annual in Cr 264212
Depreciation Cr 5653
Interest Annual Cr 84
Tax Annual Cr 5849
Net Profit Annual Cr 179146
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 195126
Cash from Investing Activity Annual Cr -187-89
Cash from Financing Annual Activity Cr -8-40
Net Cash Flow Annual Cr 0-2
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,2341,077
Fixed Assets Annual Cr 676494
Total Non Current Assets Annual Cr 782593
Total Current Assets Annual Cr 756741
Total Assets Annual Cr 1,5381,334
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 129112
ROE Annual % 1514
ROCE Annual % 1918
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2829
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 337321307285275249258
Operating Expenses Qtr Cr 253234224214210202202
Operating Profit Qtr Cr 84878371654656
Depreciation Qtr Cr 16161514141414
Interest Qtr Cr 2225011
Tax Qtr Cr 1920161716913
Net Profit Qtr Cr 62635950432736
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,151961
Operating Expenses Annual Cr 850710
Operating Profit Annual in Cr 265213
Depreciation Cr 5754
Interest Annual Cr 94
Tax Annual Cr 5849
Net Profit Annual Cr 179147
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 191123
Cash from Investing Activity Annual Cr -179-85
Cash from Financing Annual Activity Cr -13-35
Net Cash Flow Annual Cr -13
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,2421,087
Fixed Assets Annual Cr 685503
Total Non Current Assets Annual Cr 770593
Total Current Assets Annual Cr 807783
Total Assets Annual Cr 1,5771,377
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 129113
ROE Annual % 1413
ROCE Annual % 1917
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2727

Poly Medicure Technicals

EMA & SMA

Current Price
₹1,592.8
67.15 (4.4%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹1,493.71
  • 50 Day
  • ₹1,439.44
  • 100 Day
  • ₹1,360.66
  • 200 Day
  • ₹1,234.70
  • 20 Day
  • ₹1,487.60
  • 50 Day
  • ₹1,427.30
  • 100 Day
  • ₹1,372.20
  • 200 Day
  • ₹1,180.55

Poly Medicure Resistance and Support

PIVOT
₹1,576.94
Resistance
First Resistance 1,623.87
Second Resistance 1,654.93
Third Resistance 1,701.87
RSI 66.30
MFI 71.24
MACD Single Line 32.09
MACD 36.67
Support
First Resistance 1,545.87
Second Resistance 1,498.93
Third Resistance 1,467.87

Poly Medicure Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 173,499 7,214,088 41.58
Week 98,609 4,349,654 44.11
1 Month 125,855 4,693,149 37.29
6 Month 188,783 6,024,055 31.91

Poly Medicure Result Highlights

Poly Medicure Synopsis

NSE-Medical-Systems/Equip

Poly Medicure Lt is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 1068.05 Cr. and Equity Capital is Rs. 47.97 Cr. for the Year ended 31/03/2023. Poly Medicure Ltd. is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L40300DL1995PLC066923 and registration number is 066923.
Market Cap 15,286
Sales 1,191
Shares in Float 4.51
No of funds 127
Yield 0.19
Book Value 12.38
U/D Vol ratio 1.1
LTDebt / Equity 1
Alpha 0.2
Beta 0.46

Poly Medicure

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 53.16%53.31%53.31%53.33%
Mutual Funds 3.95%3.27%3.02%3.01%
Insurance Companies 0.99%0.78%0.45%0.18%
Foreign Portfolio Investors 14.49%15.61%16.21%16.33%
Individual Investors 11.35%11.1%11.11%11.18%
Others 16.06%15.93%15.9%15.97%

Poly Medicure Management

Name Designation
Mr. Devendra Raj Mehta Chairman
Mr. Himanshu Baid Managing Director
Mr. Rishi Baid Joint Managing Director
Mr. Jugal Kishore Baid Non Executive Director
Mrs. Mukulika Baid Non Executive Director
Mr. Alessandro Balboni Non Executive Director
Dr. Sandeep Bhargava Ind. Non-Executive Director
Mr. Amit Khosla Ind. Non-Executive Director
Ms. Sonal Mattoo Ind. Non-Executive Director
Mr. Prakash Chand Surana Ind. Non-Executive Director
Dr. Shailendra Raj Mehta Ind. Non-Executive Director
Dr. Ambrish Mithal Additional Director

Poly Medicure Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Poly Medicure Corporate Action

Date Purpose Remarks
2023-11-04 Quarterly Results
2023-08-07 Quarterly Results
2023-05-09 Audited Results & Final Dividend
2023-01-28 Quarterly Results
2022-11-04 Quarterly Results

Poly Medicure MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 24,370
Quant Small Cap Fund Growth 9,521
UTI Unit Linked Insurance 5,185
WhiteOak Capital Flexi Cap Fund Regular Growth 2,375
Bank of India Tax Advantage Fund Regular Growth 860

Poly Medicure FAQs

What is Share Price of Poly Medicure ?

Poly Medicure share price is ₹1,592 As on 03 December, 2023 | 23:08

What is the Market Cap of Poly Medicure ?

The Market Cap of Poly Medicure is ₹15286.2 Cr As on 03 December, 2023 | 23:08

What is the P/E ratio of Poly Medicure ?

The P/E ratio of Poly Medicure is 65.4 As on 03 December, 2023 | 23:08

What is the PB ratio of Poly Medicure ?

The PB ratio of Poly Medicure is 12.3 As on 03 December, 2023 | 23:08

Q2FY23